U.S.–East Africa center to prevent and find HIV-related cancers and speed connection to care
Official title: United States-East Africa HIV-Associated Malignancy Research Center (USEAHAMRC) for Career Development and the Prevention, Early Detection and Efficient Linkage to Care for Virus-related Cancers
Funded at University of California, San Francisco · NIH-11410157 · Data updated 2026-11-12
This program builds a U.S.–East Africa team to improve prevention, earlier detection, and faster linkage to care for people with HIV at risk for cervical cancer and Kaposi’s sarcoma.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project start | July 13, 2020 |
| Project end | June 30, 2026 |
| Funding year | 2025 |
| Award (this year) | $12,500 |
| NIH project number | 3U54CA254571-06S1 |
| Project ID | NIH-11410157 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal participants are people living with HIV in East Africa—especially women at risk for cervical cancer and patients with or at risk for Kaposi’s sarcoma—seen at clinics partnering with the center.
✕Less likely to help
People who do not have HIV, who live outside the partnering East African regions, or who have non–virus-related cancers are unlikely to directly benefit from this center’s projects.
What this research studies
This center brings together hospitals and researchers in East Africa and the U.S. to work on virus-related cancers that affect people living with HIV. It will train and support emerging East African investigators and U.S. junior scientists so local teams can lead studies. The work includes setting up better screening and diagnostic approaches and creating systems to get people from diagnosis to treatment more quickly. Research activities and pilot projects will happen at partnering clinics and hospitals in East Africa with technical support from U.S. sites.
Why it matters
Potential benefit: If successful, this work could lead to earlier diagnosis, better prevention, and faster treatment for cervical cancer and Kaposi’s sarcoma among people living with HIV in East Africa.
How similar studies have gone: Screening and HPV-based prevention have reduced cervical cancer elsewhere and linkage-to-care programs have helped in other settings, but this combined research-and-training network in East Africa is a newer, region-specific approach.
Where this research is happening
-
University of California, San Francisco
San Francisco, United States Active
Researchers
- Principal investigator: Martin, Jeffrey N — University of California, San Francisco
- Study coordinator: Martin, Jeffrey N
Related research
Other NIH-funded projects on the same topics.
-
Detecting cancer risk and treatment response in NF1 nerve tumors using cfDNA markers
A doctor-led study will test blood-based DNA markers to detect when NF1-related nerve tumors become malignant and to monitor how well treatment is working.
-
Epigenetic Basis for Controlling Aggressive IDH-Mutant Gliomas
Aims to understand and shape the epigenetic changes in IDH-mutant brain tumors to restrain their growth, which could lead to new, targeted treatment options for patients.
-
US–East Africa center to prevent and detect virus-linked cancers in people with HIV
This program builds a US–East Africa research network to train local investigators and improve prevention, earlier detection, and faster connection to care for virus-related cancers in people with HIV.
-
U.S.–East Africa program to prevent, detect early, and link people with HIV-related cancers to care
This program brings U.S. and East African teams together to help people with HIV by improving prevention, earlier detection, and faster connection to care for cancers linked to the virus.
-
Boosting TET Activity to Help Treat AML with Vitamin C
Vitamin C may help people with a type of blood cancer (AML) by boosting a natural anti-cancer pathway, potentially improving outcomes for adults with this disease.
-
Tissue tension and cancer: how stiff tissues drive cancer growth and spread
This NIH grant explores how stiff tissue environments and mechanical forces inside the body may promote cancer growth, aggression, and spread, with the goal of finding biomarkers and new drug targets that could help patients.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.